flowchart TB P["Proglucagon (GCG gene product)"] P -->|"Pancreatic α-cells<br/>cleaved by PC2"| A["Glucagon<br/>(+ GRPP, MPGF)"] P -->|"Intestinal L-cells, brain NTS<br/>cleaved by PC1/3"| B["GLP-1<br/>GLP-2<br/>Oxyntomodulin<br/>Glicentin"]
2 Secretion and Degradation: L-Cells, K-Cells, DPP-4
2.1 Where are they made?
2.1.1 GLP-1: different hormones from proglucagon by “how it is cut”
GLP-1 is made from a precursor protein called proglucagon. What is interesting is that different hormones are cut out from the same gene (GCG) depending on the cell.
- Pancreatic α-cells have the prohormone convertase PC2 and cut out glucagon
- Intestinal L-cells and neurons of the nucleus of the solitary tract (NTS) in the brainstem have PC1/3 and cut out GLP-1, GLP-2, and oxyntomodulin
There are two active forms of GLP-1, GLP-1(7-37) and GLP-1(7-36) amide; in human blood the latter predominates. The numbering starts at 7 because it was found that the active form is the originally predicted sequence GLP-1(1-37) with its six N-terminal residues removed.
2.1.2 GIP: made from its own precursor
GIP is a 42-amino-acid peptide cut out by PC1/3 from its own dedicated precursor, proGIP. It is found mainly in the K-cells of the duodenum and upper jejunum.
In textbooks, “K-cells = upper small intestine = GIP” and “L-cells = lower small intestine/colon = GLP-1”, but in reality there are GLP-1-producing cells in the upper small intestine as well, and cells that make both GIP and GLP-1 (K/L-cells) have also been reported.
2.2 What triggers secretion?
| Stimulus | GIP (K-cells) | GLP-1 (L-cells) |
|---|---|---|
| Glucose (uptake via SGLT1) | ◎ | ◎ |
| Fatty acids (FFAR1/GPR40, FFAR4/GPR120) | ◎ (strongly released by fat) | ○ |
| Amino acids, peptides | ○ | ○ |
| Bile acids (TGR5) | △ | ○ |
| Neural/endocrine signals | ○ (secreted early after a meal even though L-cells are downstream) |
Although most L-cells are located downstream in the gut, GLP-1 rises as early as 10–15 minutes after a meal. L-cells in the upper small intestine and indirect stimulation via neural and endocrine pathways are thought to be involved.
2.2.1 How gut cells “sense sugar”
In glucose sensing by enteroendocrine cells, SGLT1 (Na⁺/glucose cotransporter) is important. When glucose enters the cell together with Na⁺, the cell membrane depolarizes, voltage-gated Ca²⁺ channels open, and the hormone is released.
2.3 How are they destroyed? DPP-4
The biggest weakness of GLP-1 and GIP is that they are destroyed in the blood within minutes.
When DPP-4 (dipeptidyl peptidase-4) finds a peptide whose second amino acid from the N-terminus is alanine (Ala) or proline (Pro), it cuts off the two N-terminal residues together.
GLP-1(7-36)NH2: H-A-E-G-T-F-T-S-D-V-S-S-Y-L-E-G-Q-A-A-K-E-F-I-A-W-L-V-K-G-R-NH2
└┬┘
cleaved by DPP-4 → GLP-1(9-36)NH2 (barely activates the receptor)
GIP(1-42): Y-A-E-G-T-F-I-S-D-Y-S-I-A-M-D-K-I-H-Q-Q-D-F-V-N-W-L-L-A-Q-K-G-K-K-N-D-W-K-H-N-I-T-Q
└┬┘
cleaved by DPP-4 → GIP(3-42) (barely activates the receptor)
| GLP-1 | GIP | |
|---|---|---|
| Two N-terminal residues | His-Ala | Tyr-Ala |
| Plasma half-life (active form) | about 1–2 min | about 5–7 min |
| Main route of elimination | Kidney | Kidney |
For GLP-1, degradation by DPP-4 on the endothelium of the intestinal capillaries begins the moment it leaves the L-cell. It is further degraded in the liver, so it is estimated that only about 10–15% of the secreted active GLP-1 reaches the systemic circulation.
flowchart LR L["L-cells"] -->|"Active GLP-1<br/>100%"| C["Intestinal capillaries<br/>(DPP-4 on endothelium)"] C -->|"about 25%"| PV["Portal vein"] PV --> Liv["Liver<br/>(further degradation)"] Liv -->|"about 10–15%"| Sys["Systemic circulation<br/>→ pancreas, brain, etc."] C -.->|"mostly converted<br/>to GLP-1(9-36)"| Inact["Inactive form"]
- Physiological GLP-1 is less a “hormone that circulates through the whole body” than a local signal that acts on vagal afferent fibers near the gut or is sensed in the portal vein
- Drugs (GLP-1RAs), on the other hand, are not destroyed by DPP-4 and stay in the blood for days. They keep stimulating receptors throughout the body with an exposure pattern completely different from that of physiological GLP-1
Two approaches to overcome this “rapidly destroyed” property ——
- Block the enzyme that destroys it (DPP-4 inhibitors)
- Make hormone analogues that are not destroyed (GLP-1 receptor agonists)
—— are the starting points for the drugs covered in Chapter 6.
2.4 Summary
- GLP-1 is cut out of proglucagon by PC1/3, and glucagon is cut out of the same precursor by PC2
- GIP is secreted from K-cells (upper small intestine) and GLP-1 from L-cells (mainly lower small intestine and colon) in response to nutrient stimuli
- In both, the second residue from the N-terminus is Ala, and they are inactivated by DPP-4 within minutes